Results 71 to 80 of about 4,958,090 (306)
Degradation mechanism of the von Willebrand factor A2 domain by nattokinase
FEBS Letters, EarlyView.Nattokinase, a natto‐derived protease, exhibits potent antithrombotic effects. This study demonstrates that nattokinase directly cleaves the von Willebrand factor (vWF) A2 domain in vitro. Unlike the native regulator ADAMTS13, nattokinase degrades folded vWF independently of shear stress.
Ryuichi Hyakumoto +3 more
wiley +1 more source
Study on the Relationship Between the Number of Adverse Drug Reactions of Essential Drugs and Visits: Based on Vector Autoregressive Model. [PDF]
Risk Manag Healthc Policy, 2023 Tang W, Chen H, Zhang Z, Wu G, Lin Y.
europepmc +1 more source
FEBS Letters, EarlyView.We present robust protocols for the preparation of supported lipid bilayers (SLBs) incorporating either Salmonella smooth LPS or outer membrane vesicles (OMVs). We use a combination of quartz crystal microbalance with dissipation (QCM‐D) and fluorescence microscopy to both characterize the SLBs of various compositions and to probe their interactions ...
Hudson P. Pace +6 more
wiley +1 more source
, 1997 Korean ed. with: Drugs in general practice. EURO reports and studies no.
WHO Expert Committee on the Use of Essential Drugs (1995 : Geneva, Switzerland) +1 more
core
Evaluating the availability of essential drugs for hypertension, diabetes and asthma in rural Rwanda, 2018. [PDF]
Public Health Action, 2021 Mbonyinshuti F +7 more
europepmc +1 more source
FEBS Letters, EarlyView.Proteostasis and the gut microbiota play a key role in shaping host physiology. Microbiota‐derived metabolites, vitamins, and RNA modulate host proteostasis. Findings from model systems, including C. elegans, indicate microbes can either stabilize or disrupt host proteostasis.
Abhishek Anil Dubey, Maria Ermolaeva
wiley +1 more source
Future strategy : Action Programme on Essential Drugs
, 1993 ONLINEWHO/DAP/94.4.
WHO Action Programme on Essential Drugs
core
Action Programme on Essential Drugs : progress report 1994, interim report of the biennium 1994-1995 [PDF]
, 1995 ONLINEDAP/MAC(7)/95.4.
WHO Action Programme on Essential Drugs
core +1 more source
Revista da Sociedade Brasileira de Medicina Tropical, 2011 INTRODUCTION: The emergence of drug resistance is one of the main problems concerning malaria treatment. The use of counterfeit and/or substandard antimalarial drugs can contribute to the development of parasite resistance.
Fernando Henrique Andrade Nogueira +3 more
doaj +1 more source